Stock DNA
Pharmaceuticals & Biotechnology
JPY 50,934 Million (Small Cap)
12.00
NA
0.00%
0.56
20.91%
2.80
Revenue and Profits:
Net Sales:
5,218 Million
(Quarterly Results - Jan 2026)
Net Profit:
1,132 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.48%
0%
5.48%
6 Months
2.54%
0%
2.54%
1 Year
-16.14%
0%
-16.14%
2 Years
-11.25%
0%
-11.25%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Japan Eyewear Holdings Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.42%
EBIT Growth (5y)
28.17%
EBIT to Interest (avg)
12.02
Debt to EBITDA (avg)
1.76
Net Debt to Equity (avg)
0.69
Sales to Capital Employed (avg)
0.54
Tax Ratio
19.79%
Dividend Payout Ratio
53.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.71%
ROE (avg)
22.85%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.97
EV to EBIT
10.86
EV to EBITDA
8.20
EV to Capital Employed
2.18
EV to Sales
3.45
PEG Ratio
0.41
Dividend Yield
NA
ROCE (Latest)
20.07%
ROE (Latest)
24.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jan'26 - YoY
Jan'26
Jan'25
Change(%)
Net Sales
5,218.00
4,571.00
14.15%
Operating Profit (PBDIT) excl Other Income
2,150.00
1,851.00
16.15%
Interest
88.00
73.00
20.55%
Exceptional Items
-26.00
0.00
Consolidate Net Profit
1,132.00
1,571.00
-27.94%
Operating Profit Margin (Excl OI)
314.90%
307.60%
0.73%
USD in Million.
Net Sales
YoY Growth in quarter ended Jan 2026 is 14.15% vs 19.07% in Jan 2025
Consolidated Net Profit
YoY Growth in quarter ended Jan 2026 is -27.94% vs 92.52% in Jan 2025
Annual Results Snapshot (Consolidated) - Jan'26
Jan'26
Jan'25
Change(%)
Net Sales
18,640.00
16,666.00
11.84%
Operating Profit (PBDIT) excl Other Income
7,858.00
6,996.00
12.32%
Interest
338.00
421.00
-19.71%
Exceptional Items
-26.00
0.00
Consolidate Net Profit
3,783.00
3,994.00
-5.28%
Operating Profit Margin (Excl OI)
319.00%
319.30%
-0.03%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2026 is 11.84% vs 23.20% in Jan 2025
Consolidated Net Profit
YoY Growth in year ended Jan 2026 is -5.28% vs 69.09% in Jan 2025
About Japan Eyewear Holdings Co. Ltd. 
Japan Eyewear Holdings Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






